← Back to Dashboard

Juluca

Integrase strand transfer inhibitor + NNRTI

Constituent drugs (2)

Dolutegravir

Loading structure...
3D not available

Rilpivirine

Loading structure...
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral integrase + RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Nov. 26, 2018fixed-dose combination of Dolutegravir, Rilpivirine.